Institution view

Second Affiliated Hospital, School of Medicine, Zhejiang University

Programs currently tracked for this institution in the public Translational Deal Radar dataset.

Car Nk

anti-CD19 CAR-NK

anti-CD19 CAR-NK is flagged as a platform signal because it has an active early-phase oncology cell-therapy trial at Second Affiliated Hospital, School of Medicine, Zhejiang University, with a possible patent signal linked through modality_match. Manual review is still required.

Phase1 · Unknown

View asset